Myriad Genetics Underscores Commitment to Cancer Care Continuum with New Data Presentations at SGO Annual Meeting
Go back to Myriad Genetics Underscores Commitment to Cancer Care Continuum with New Data Presentations at SGO Annual Meeting| Myriad Genetics, Inc. (NASDAQ: MYGN) | Delayed: 4.50 -0.04 (0.88%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.54 | 52 Week High | $45.34 | |||
| Open | $4.54 | 52 Week Low | $15.92 | |||
| Day High | $4.62 | P/E | 1.93 | |||
| Day Low | $4.42 | EPS | $2.33 | |||
| Volume | 1,271,242 | |||||
